Evidence map›Paper›PMID 32462398›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2020

Impact of the COVID-19 pandemic in nuclear medicine departments: preliminary report of the first international survey.

Salvatore Annunziata, Matteo Bauckneht, Domenico Albano, Giovanni Argiroffi, Diletta Calabrò, Elisabetta Abenavoli, Flavia Linguanti, Riccardo Laudicella, Young Committee of the Italian Association of Nuclear Medicine (AIMN)

Open access · bronzeAbstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Lutetium [European journal of nuclear medicine and molecular imaging · 2024
    Observational
  4. Article
  5. Temporary Reactive Response of Axillary Lymph Nodes to COVID-19 Vaccination onJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  6. Nuclear medicine practice in the field of infection and inflammation imaging: a pragmatical survey.European journal of nuclear medicine and molecular imaging · 2022
    Article
  7. Incidental Findings Suggestive of COVID-19 Pneumonia in Oncologic Patients UndergoingJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  8. Nuclear Medicine Departments in the Era of COVID-19.Seminars in nuclear medicine · 2022
    Review
  9. Review
  10. The Impact of COVID-19 on Nuclear Medicine in Europe.Seminars in nuclear medicine · 2022
    Review
  11. Article
  12. Review
  13. Positron emission tomography in the COVID-19 pandemic era.European journal of nuclear medicine and molecular imaging · 2021
    Review
  14. Prevalence of interstitial pneumonia suggestive of COVID-19 atEuropean journal of nuclear medicine and molecular imaging · 2021
    Observational
  15. Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021
    Article
  16. A comprehensive review of imaging findings in COVID-19 - status in early 2021.European journal of nuclear medicine and molecular imaging · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Salvatore AnnunziataNuclear Medicine Unit, IRCCS Regina Elena National Cancer Institute, via Elio Chianesi 53, 00144, Rome, Italy. salvatoreannunziata@live.it.
Matteo BaucknehtNuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Domenico AlbanoDepartment of Nuclear Medicine, University of Brescia and Spedali Civili Brescia, Brescia, Italy.
Giovanni ArgiroffiDepartment of Health Sciences, University of Milan, Milan, Italy.
Diletta CalabròNuclear Medicine, DIMES University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
Elisabetta AbenavoliNuclear Medicine Unit, Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
Flavia LinguantiNuclear Medicine Unit, Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
Riccardo LaudicellaDepartment of Biomedical and Dental Sciences and of Morpho-Functional Imaging, Nuclear Medicine Unit, University of Messina, Messina, Italy.
Young Committee of the Italian Association of Nuclear Medicine (AIMN)
University of Florence · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITOspedale Policlinico San Martino · ITPoliclinico S.Orsola-Malpighi · ITUniversity of Brescia · ITUniversity of Messina · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCoronavirus disease-19 (COVID-19) pandemic is challenging the availability of hospital resources worldwide. The Young Group of the Italian Association of Nuclear Medicine (AIMN) developed the first international survey to evaluate the impact of COVID-19 in nuclear medicine (NM). The aim of this study was to perform a preliminary report of the ongoing survey.

methodsA questionnaire of thirty questions was prepared for all NM professionals addressing three main issues: (1) new scheduling praxes for NM diagnostic and therapeutic procedures, (2) assistance of patients with diagnosed or suspected COVID-19, and (3) prevention of COVID-19 spreading in the departments. An invitation to the survey was sent to the corresponding authors of NM scientific papers indexed in SCOPUS in 2019. Personal data were analysed per individual responder. Organisation data were evaluated per single department.

resultsTwo-hundred and ninety-six individual responders from 220 departments were evaluated. Most of the responders were from Europe (199/296, 67%). Approximately, all departments already changed their scheduling praxes due to the pandemic (213/220, 97%). In most departments, scheduled diagnostic and therapeutic procedures were allowed but quantitatively reduced (112/220, 51%). A significant reduction of diagnostic and therapeutic procedures (more than 20%) affected 198/220 (90%) and 158/220 (72%) departments, respectively. Incidental COVID-19 signs in NM exams occurred in 106/220 departments (48%). Few departments were closed or shifted to assist patients with COVID-19 (36/220, 16%). Most of the responders thought that pandemic would not permanently change the work of NM departments in the future (189/296, 64%).

conclusionsAccording to this preliminary report of the first international survey, COVID-19 heavily impacted NM departments and professionals. New praxes for NM procedures, assistance, and prevention of COVID-19 have been applied during the pandemic.

Indexed as

InternationalityNuclear MedicinePandemicsSurveys and QuestionnairesCoronavirus InfectionsCOVID-19Hospital DepartmentsHumansPneumonia, ViralCOVID-19Nuclear medicineSurvey

Identifiers

PMID32462398
PMCPMC7251803
OpenAlexW3028837366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.